TNGX
Tango Therapeutics Inc
21.80$
-0.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -290.1% | -505.7% | -585.0% | -118.8% | -287.7% | -890.1% | -773.3% | -1,148.0% | -57.5% | – | – | – | -267.4% | |
| 5.7% | 11.4% | 9.7% | 3.2% | 5.4% | 15.1% | 11.5% | 19.6% | 1.0% | – | – | – | 3.6% | |
| 45.3% | 89.8% | 103.8% | 37.9% | 61.8% | 181.2% | 134.6% | 206.5% | 12.3% | – | – | – | 74.9% | |
| -149.2% | -13.8% | -105.6% | -30.1% | -101.5% | -173.6% | -185.8% | -162.1% | -101.1% | – | – | – | -117.0% | |
| 0.1% | 4.2% | 3.0% | 1.6% | 1.0% | 3.0% | 0.9% | 19.6% | 0.3% | – | – | – | 0.7% | |
| -528.0% | 623.3% | -173.1% | 63.9% | 280.6% | 1,264.5% | 567.5% | 527.4% | 88.2% | – | – | – | -974.9% | |
| 748.0% | 27.0% | 664.2% | 6.6% | 20.7% | 23.5% | 0.0% | 18.3% | 4.7% | – | – | – | 1,810.7% | |
| -70.1% | 144.6% | -93.9% | -48.3% | 13.6% | 397.9% | -205.8% | -602.3% | 35.4% | – | – | – | 568.4% | |
| -290.3% | -509.9% | -588.0% | -120.4% | -288.7% | -893.2% | -774.3% | -1,167.7% | -57.8% | – | – | – | -268.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.